An inverse relationship between peroxisome proliferator–activated receptor γ and allergic airway inflammation in an allergen challenge model
- 30 November 2005
- journal article
- research article
- Published by Elsevier BV in Annals of Allergy, Asthma & Immunology
- Vol. 95 (5), 468-473
- https://doi.org/10.1016/s1081-1206(10)61173-8
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Peroxisome proliferator–activated receptor γ is expressed in airways and inhibits features of airway remodeling in a mouse asthma model☆Journal of Allergy and Clinical Immunology, 2004
- Asthma: Mechanisms of Disease Persistence and ProgressionAnnual Review of Immunology, 2004
- Peroxisome proliferator-activated receptor-γ: therapeutic target for diseases beyond diabetes: quo vadis?Expert Opinion on Investigational Drugs, 2004
- Peroxisome Proliferator–activated Receptors α and γ Down-regulate Allergic Inflammation and Eosinophil ActivationThe Journal of Experimental Medicine, 2003
- PPAR‐α and ‐γ but not ‐δ agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF‐κB‐independent effectBritish Journal of Pharmacology, 2003
- Antidiabetic PPARγ-Activator Rosiglitazone Reduces MMP-9 Serum Levels in Type 2 Diabetic Patients With Coronary Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Emerging roles of PPARS in inflammation and immunityNature Reviews Immunology, 2002
- The Mechanisms of Action of PPARsAnnual Review of Medicine, 2002
- Nitric oxide regulation of asthmatic airway inflammation with segmental allergen challenge☆☆☆Journal of Allergy and Clinical Immunology, 1999
- Standardization of bronchial inhalation challenge proceduresJournal of Allergy and Clinical Immunology, 1975